News Category
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz as head of supply chain and business process administratio...
Helix BioPharma Corp. closes a C$3.67 million private placement of convertible debentures to fund working capital and drug development programs.
